# Tacrolimus Versus Cyclosporine for Immunosuppression After Lung Transplantation

> **NCT01429844** · PHASE3 · COMPLETED · sponsor: **Universitätsklinikum Hamburg-Eppendorf** · enrollment: 274 (actual)

## Conditions studied

- Bronchiolitis Obliterans
- Immunosuppression

## Interventions

- **DRUG:** Tacrolimus
- **DRUG:** Cyclosporine

## Key facts

- **NCT ID:** NCT01429844
- **Lead sponsor:** Universitätsklinikum Hamburg-Eppendorf
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** 2007-10
- **Final completion:** 2010-08
- **Target enrollment:** 274 (ACTUAL)
- **Last updated:** 2011-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01429844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01429844, "Tacrolimus Versus Cyclosporine for Immunosuppression After Lung Transplantation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01429844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*